Stay updated on TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ACTME study record for TIL and anti-PD-1 treatment in metastatic melanoma is displayed, with its trial design, participant criteria, interventions, outcome measures, and record history.
    Difference
    54%
    Check dated 2026-11-09T13:16:21.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0 in the footer.
    Difference
    0.2%
    Check dated 2026-11-02T12:45:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-26T12:57:19.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T13:35:41.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:32:23.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden text and the Home link, eliminating the error message and restoring the standard page layout.
    Difference
    0.5%
    Check dated 2026-09-28T16:37:44.000Z thumbnail image

Stay in the know with updates to TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.